NEO Gross Margin

The Gross Margin of NeoGenomics, Inc. (NEO) is 43.21%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NEO Gross Margin - Historical Value

Date	Value
2025-12-31	43.21%
2024-12-31	43.92%
2023-12-31	41.34%
2022-12-31	36.86%
2021-12-31	38.61%
2020-12-31	41.81%
2019-12-31	48.14%
2018-12-31	45.97%
2017-12-31	42.45%
2016-12-31	42.32%

NEO Gross Margin - Peers Comparison

Ticker	Name	Value
MTD	Mettler-Toledo International Inc.	59.37%
QTRX	Quanterix Corporation	46.77%
RIVU	Rivulet Media Inc	50.00%
TMO	Thermo Fisher Scientific Inc.	40.93%
BLI	Berkeley Lights Inc	68.43%
FLDM	Fluidigm Corp	53.13%
HBIO	Harvard Bioscience Inc	57.67%
LMNX	Luminex Corp	59.39%
ARCH.V	Arch Biopartners Inc	20.22%
AVTR	Avantor, Inc.	32.65%
BIO	Bio-Rad Laboratories, Inc.	52.01%
IQV	IQVIA Holdings Inc	33.29%
RGEN	Repligen Corporation	52.65%
CDXS	Codexis, Inc.	86.73%
MRVI	Maravai LifeSciences Holdings Inc	18.30%
PBSV	Pharma-Bio Serv Inc	32.33%
ABCL	AbCellera Biologics Inc.	7775.20%
BNGO	Bionano Genomics, Inc.	46.25%
CDXC	Chromadex Corp	61.84%
A	Agilent Technologies Inc	52.73%
PSNL	Personalis, Inc.	22.65%
SONA.CN	Sona Nanotech Inc	7775.20%
SHC	Sotera Health Company	55.48%
CRL	Charles River Laboratories International, Inc.	34.98%
PACB	Pacific Biosciences of California, Inc.	31.22%
SEER	Seer, Inc.	51.06%
MEDP	Medpace Holdings, Inc.	30.06%
NSTG	NanoString Technologies Inc	48.55%
PKI	PerkinElmer Inc	6008.00%
BASI	Inotiv Inc	3015.93%
ILMN	Illumina Inc	66.61%
IPA.V	Immunoprecise Antibodies Ltd	64.41%
HLMB	Swiftsure International Inc	65.54%
INIS	RADNOSTIX, INC.	58.93%
WAT	Waters Corp	59.22%
ADPT	Adaptive Biotechnologies Corporation	74.24%
CGEN	Compugen Ltd.	94.01%
CSBR	Champions Oncology Inc	48.00%